Page last updated: 2024-08-18

quinuclidines and carfilzomib

quinuclidines has been researched along with carfilzomib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sebestyén, Z; Szabó, B; Szepesi, K	1
Amati, B; Amato, A; Ciani, Y; Dalla, E; Del Sal, G; Eterno, V; Gaweda-Walerych, K; Ingallina, E; Lisek, K; Morelli, MJ; Piazza, S; Rajkowska, K; Rosato, A; Sommaggio, R; Tonelli, C; Walerych, D; Wiśniewski, JR; Zambelli, A	1

Reviews

1 review(s) available for quinuclidines and carfilzomib

Article	Year
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin]. Acta pharmaceutica Hungarica, 2013, Volume: 83, Issue:2 Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole	2013

Article

Year

[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].

Acta pharmaceutica Hungarica, 2013, Volume: 83, Issue:2

Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole

2013

Other Studies

1 other study(ies) available for quinuclidines and carfilzomib

Article	Year
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. Nature cell biology, 2016, Volume: 18, Issue:8 Topics: Animals; Antineoplastic Agents; Humans; Mice; MicroRNAs; Mutant Proteins; Mutation, Missense; Neoplasm Metastasis; NF-E2-Related Factor 2; Oligopeptides; Proteasome Endopeptidase Complex; Proteome; Quinuclidines; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53	2016

Article

Year

Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer.

Nature cell biology, 2016, Volume: 18, Issue:8

Topics: Animals; Antineoplastic Agents; Humans; Mice; MicroRNAs; Mutant Proteins; Mutation, Missense; Neoplasm Metastasis; NF-E2-Related Factor 2; Oligopeptides; Proteasome Endopeptidase Complex; Proteome; Quinuclidines; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53

2016